Prenetics Global has announced a landmark $1 billion growth financing deal for its AI-native wellness brand, IM8. The funding, provided by General Catalyst’s Customer Value Fund, is designed to aggressively scale the marketing efforts of the rapidly expanding supplement company co-founded by David Beckham. This strategic partnership utilizes an innovative, non-dilutive capital structure to fuel IM8's global ambitions without issuing new equity.
An Innovative Financing Structure
The arrangement provides IM8 with up to $1 billion to cover as much as 70% of its marketing expenditures. In exchange, General Catalyst will receive a capped portion of the income generated by the specific customer cohorts financed through the program. This unique model aligns risk and reward, ensuring that repayment is directly tied to the success of the marketing investment.
Once General Catalyst recovers its initial investment plus a predetermined return for a given cohort, all subsequent revenue from those customers accrues entirely to IM8. This structure is purely a financial liability and involves no warrants, equity, or convertible instruments, preserving value for existing Prenetics shareholders. The partnership offers a third way for growth, avoiding the traditional choice between dilutive fundraising and slower, cash-constrained expansion.
Fueling Unprecedented Growth
IM8 has established itself as the fastest-growing premium supplement brand on record, having delivered over 50 million servings since its launch. This momentum prompted Prenetics to raise its full-year 2026 revenue guidance for IM8 to between $210 and $220 million. The company projects reaching a $300 million annualized revenue run-rate by the end of 2026.
The brand's impressive performance is underpinned by strong unit economics, with every dollar spent on customer acquisition returning $1.44 in gross profit across mature cohorts. This proven efficiency and high customer retention were central to General Catalyst's rigorous due diligence and billion-dollar commitment. These returns are expected to compound over time as the subscriber base grows.
AI-Driven Marketing and Expansion
Operating as an AI-native organization, IM8 embeds machine learning across its entire business, from marketing to customer retention. The new capital will be deployed through this sophisticated engine to optimize advertising spend across all 43 of its current markets. This technology enables continuous, automated experimentation at a scale that few consumer companies can match.
At any given moment, thousands of advertisements are being tested, while landing pages and website experiences undergo constant multivariate testing. Predictive models analyze cohort quality and lifetime value in near real-time, directing marketing investment to the most effective channels. This data-driven machine, which compounds in efficiency as it learns, was a key factor in securing the financing.
Strategic Vision and Market Impact
Danny Yeung, CEO of Prenetics, stated that the financing validates the strength of IM8's cohort economics and accelerates its mission to build a global consumer health brand. General Catalyst praised IM8's best-in-class unit economics and remarkable customer retention data. The partnership is seen as a vehicle to solidify IM8 as a leading brand for the next decade.
This capital infusion allows IM8 to invest more aggressively in brand building while preserving its balance sheet for other strategic priorities. The company can now focus its cash reserves on product innovation, clinical research, and new category launches. Upcoming products, including IM8 Hydration and a premium gummies line, are set to significantly expand the brand's addressable market.
In conclusion, the $1 billion financing from General Catalyst marks a pivotal moment for Prenetics and its breakout brand, IM8. The deal not only provides substantial capital for growth but also validates the company's AI-powered, high-retention business model. This strategic partnership positions IM8 to rapidly accelerate its global expansion and cement its status as a dominant force in the consumer wellness industry.